Research programme: topical molluscum contagiosum therapeutics - Fox Chase Chemical Diversity Center/Universtiy of Pennsylvania
Latest Information Update: 04 Jul 2016
At a glance
- Originator Fox Chase Chemical Diversity Center; University of Pennsylvania
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Molluscum contagiosum
Most Recent Events
- 04 Jul 2016 Preclinical trials in Molluscum contagiosum in USA (Topical)
- 04 Jul 2016 Creating NP from Cortellis list project - NP created; requested press release to add to Citations - http://www.fc-cdci.com/PressReleases/Molluscum_03.21.16.html